TSX:LABS (MediPharm Labs Corp.)
About LABS
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
MediPharm Labs Corp. (TSX: LABS) Latest News
Cannabis Stocks
3 Smoking-Hot Cannabis 2.0 Stocks That Could Grow Tenfold Over the Next Decade
Investing
Canadians: 3 Stocks Under $5 to Watch in July
Cannabis Stocks
A Medical Cannabis Stock for Millennial Investors
Cannabis Stocks
Top 2 Cannabis Stocks to Buy for the Next Decade
Cannabis Stocks
2 Attractive Small-Cap Marijuana Stocks to Watch
Cannabis Stocks
Why This Is the Best Cannabis Stock in Canada
Cannabis Stocks
Buy the Dip Now: 3 Cannabis Stocks
Cannabis Stocks
Cannabis Investing: 3 Promising Strategies Ahead of Cannabis 2.0
Cannabis Stocks
3 Weed Stocks Ready for Epic Growth
Cannabis Stocks
2 Underrated Pot Stocks to Buy Ahead of Cannabis 2.0
Cannabis Stocks
Marijuana Stocks’ Greatest Hits: Top 3 Buys Today
Cannabis Stocks
2 Cannabis Extraction Companies to Buy Ahead of October
1❯